Auxly Cannabis - CEO, Hugo Alves
CEO, Hugo Alves
Source: Canadian Lawyer
  • Auxly Cannabis (TSXV:XLY) subsidiary, Dosecann, has entered into an agreement with wellness company, GSW Creative Corporation Canada
  • GSW has contracted Dosecann to manufacture and distribute its wellness vape devices
  • Dosecann will receive an exclusive license to the intellectual property required to manufacture, distribute, and sell GSW’s dosist products
  • The agreement is for a three-year term, but is subject to renewal for an additional two years
  • Auxly Cannabis (XLY) is down 1.61 per cent and is currently trading at C$0.30 per share

Auxly Cannabis (TSXV:XLY) subsidiary, Dosecann, has entered into an agreement with wellness company, GSW Creative Corporation Canada.

GSW, doing business as dosist, has contracted Dosecann to manufacture and distribute dosist-branded wellness vape products. These include the new dose pen 100, a range of high-potency formulas called thc-plus, and a rechargeable dose pen system.

The company will give Dosecann an exclusive license to the intellectual property required to manufacture, distribute, and sell the products. In return, Auxly’s subsidiary will receive certain fees for such manufacturing and distribution.

Dosecann will manufacture the vape devices at its facility located on Prince Edward Island. The company will also use its well-established national distribution channels to bring the new dosist products to market. 

The agreement has a three-year term, but is subject to renewal for an additional two years.

Auxly’s CEO, Hugo Alves, said the company is thrilled to expand its subsidiary’s business by manufacturing dosist’s wellness devices.

“Our arrangement with dosist allows us to leverage our sales and distribution reach, and maximise the use of Dosecann’s manufacturing capacity and expertise in making the highest quality products for consumers.

“As a premium wellness-focused brand with an international track record of success in California and here in Canada, dosist is a perfect fit within Auxly’s existing portfolio of branded cannabis products.

“We look forward to building our relationship with dosist, and continuing to deliver a compelling portfolio of cannabis products that delight consumers,” he said.

Auxly Cannabis (XLY) is down 1.61 per cent and is currently trading at C$0.30 per share at 2:55pm EDT.

More From The Market Online

The Market Online’s Weekly Cannabis Report – June 21, 2024

A Canadian cannabis pharmaceutical stock, has signed a licensing agreement with Remidose Aerosols to acquire its metered dose inhaler.

MediPharm bolsters revenue with new medical cannabis products

MediPharm Labs (TSX:LABS), a cannabis pharmaceutical stock, increases revenue through a new licensing agreement with Remidose Aerosols.

Justera Health to acquire cannabis brand Port North Extracts

Justera Health (CSE:VTAL) reveals it will acquire 100 per cent of the issued and outstanding shares of Port North Extracts.

The Market Online’s Weekly Cannabis Report – June 14, 2024

A top Mexican cannabis and CBD company revealed it has executed the first purchase order of products from Restorative Botanicals in the U.S.